Cardiac-specific overexpression of caveolin-3 attenuates cardiac hypertrophy and increases natriuretic peptide expression and signaling

Journal of the American College of Cardiology

Volumn 57, Issue 22, 2011, Pages 2273-2283

  Horikawa, Yousuke T ^a   Panneerselvam, Mathivadhani ^a   Kawaraguchi, Yoshitaka ^a   Tsutsumi, Yasuo M ^b   Ali, Sameh S ^a   Balijepalli, Ravi C ^f   Murray, Fiona ^c   Head, Brian P ^a   Niesman, Ingrid R ^a   Rieg, Timo ^d,e   Vallon, Volker ^c,d,e   Insel, Paul A ^c,e   Patel, Hemal H ^a   Roth, David M ^a,d  

^a University of California   (United States)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c San Diego   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^f UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

atrial natriuretic peptide (ANP); brain natriuretic peptide (BNP); caveolae; caveolin; hypertrophy; remodeling

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CAVEOLIN 3; CYCLIC GMP; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CELL SURVIVAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME IMMUNOASSAY; GENE OVEREXPRESSION; HEART FUNCTION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; MALE; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; SARCOLEMMA; SIGNAL TRANSDUCTION; TRANSGENE;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CARDIOMEGALY; CAVEOLAE; CAVEOLIN 3; CYCLIC GMP; HEART FAILURE; IMMUNOENZYME TECHNIQUES; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MYOCYTES, CARDIAC; NATRIURETIC PEPTIDE, BRAIN; NFATC TRANSCRIPTION FACTORS; RNA, MESSENGER;

EID: 79957577739     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.12.032     Document Type: Article

References (34)

1. J. Heineke, and J.D. Molkentin Regulation of cardiac hypertrophy by intracellular signalling pathways Nat Rev Mol Cell Biol 7 2006 589 600 (Pubitemid 44325350)
2. L.J. Pike Lipid rafts: bringing order to chaos J Lipid Res 44 2003 655 667 (Pubitemid 37279667)
3. G.E. Palade An electron microscope study of the mitochondrial structure J Histochem Cytochem 1 1953 188 211
4. H.H. Patel, F. Murray, and P.A. Insel Caveolae as organizers of pharmacologically relevant signal transduction molecules Annu Rev Pharmacol Toxicol 48 2008 359 391 (Pubitemid 351738158)
5. D.D. Doyle, S.K. Ambler, J. Upshaw-Earley, A. Bastawrous, G.E. Goings, and E. Page Type B atrial natriuretic peptide receptor in cardiac myocyte caveolae Circ Res 81 1997 86 91 (Pubitemid 27272986)
6. W.M. Krajewska, and I. Maslowska Caveolins: structure and function in signal transduction Cell Mol Biol Lett 9 2004 195 220 (Pubitemid 38902217)
7. T.M. Williams, and M.P. Lisanti The caveolin proteins Genome Biol 5 2004 214
8. S.E. Woodman, D.S. Park, and A.W. Cohen Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade J Biol Chem 277 2002 38988 38997 (Pubitemid 35154765)
9. A. Koga, N. Oka, T. Kikuchi, H. Miyazaki, S. Kato, and T. Imaizumi Adenovirus-mediated overexpression of caveolin-3 inhibits rat cardiomyocyte hypertrophy Hypertension 42 2003 213 219 (Pubitemid 36944599)
10. T. Nishikimi, N. Maeda, and H. Matsuoka The role of natriuretic peptides in cardioprotection Cardiovasc Res 69 2006 318 328 (Pubitemid 43098788)
11. S. Rubattu, S. Sciarretta, V. Valenti, R. Stanzione, and M. Volpe Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases Am J Hypertens 21 2008 733 741 (Pubitemid 351913612)
12. C.Y. Lee, and J.C. Burnett Jr Natriuretic peptides and therapeutic applications Heart Fail Rev 12 2007 131 142 (Pubitemid 46916959)
13. T.M. Newman, N.J. Severs, and J.N. Skepper The pathway of atrial natriuretic peptide releasefrom cell to plasma Cardioscience 2 1991 263 272
14. Y.M. Tsutsumi, Y.T. Horikawa, and M.M. Jennings Cardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking ischemic preconditioning Circulation 118 2008 1979 1988
15. T. Rieg, T. Tang, and F. Murray Adenylate cyclase 6 determines cAMP formation and aquaporin-2 phosphorylation and trafficking in inner medulla J Am Soc Nephrol 21 2010 2059 2068
16. H.A. Rockman, R.S. Ross, and A.N. Harris Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy Proc Natl Acad Sci U S A 88 1991 8277 8281 (Pubitemid 21915339)
17. H.H. Patel, B.P. Head, and H.N. Petersen Protection of adult rat cardiac myocytes from ischemic cell death: role of caveolar microdomains and delta-opioid receptors Am J Physiol Heart Circ Physiol 291 2006 H344 H350
18. J.C. Hunter, J.C. Kostyak, J.L. Novotny, A.M. Simpson, and D.H. Korzick Estrogen deficiency decreases ischemic tolerance in the aged rat heart: roles of PKCdelta, PKCepsilon, Akt, and GSK3beta Am J Physiol Regul Integr Comp Physiol 292 2007 R800 R809
19. E. Page, J. Upshaw-Earley, and G.E. Goings Localization of atrial natriuretic peptide in caveolae of in situ atrial myocytes Circ Res 75 1994 949 954 (Pubitemid 24323530)
20. H. Okawa, H. Horimoto, S. Mieno, Y. Nomura, M. Yoshida, and S. Shinjiro Preischemic infusion of alpha-human atrial natriuretic peptide elicits myoprotective effects against ischemia reperfusion in isolated rat hearts Mol Cell Biochem 248 2003 171 177 (Pubitemid 36833656)
21. P.M. Oliver, J.E. Fox, and R. Kim Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A Proc Natl Acad Sci U S A 94 1997 14730 14735 (Pubitemid 28041442)
22. T. Horio, T. Nishikimi, F. Yoshihara, H. Matsuo, S. Takishita, and K. Kangawa Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes Hypertension 35 2000 19 24 (Pubitemid 30054231)
23. T. Maki, T. Horio, and F. Yoshihara Effect of neutral endopeptidase inhibitor on endogenous atrial natriuretic peptide as a paracrine factor in cultured cardiac fibroblasts Br J Pharmacol 131 2000 1204 1210
24. Y. Saito, K. Nakao, and K. Nishimura Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function Circulation 76 1987 115 124 (Pubitemid 17093199)
25. J.W. Knowles, G. Esposito, and L. Mao Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice J Clin Invest 107 2001 975 984 (Pubitemid 32328002)
26. M.D. Costa, L.V. Bosc, M.P. Majowicz, N.A. Vidal, A.M. Balaszczuk, and C.T. Arranz Atrial natriuretic peptide modifies arterial blood pressure through nitric oxide pathway in rats Hypertension 35 2000 1119 1123 (Pubitemid 30327267)
27. K.U. Kotlo, M.M. Rasenick, and R.S. Danziger Evidence for cross-talk between atrial natriuretic peptide and nitric oxide receptors Mol Cell Biochem 338 2010 183 189
28. Y. Tsujita, J. Muraski, and I. Shiraishi Nuclear targeting of Akt antagonizes aspects of cardiomyocyte hypertrophy Proc Natl Acad Sci U S A 103 2006 11946 11951 (Pubitemid 44215791)
29. H. Kuga, K. Ogawa, and A. Oida Administration of atrial natriuretic peptide attenuates reperfusion phenomena and preserves left ventricular regional wall motion after direct coronary angioplasty for acute myocardial infarction Circ J 67 2003 443 448 (Pubitemid 36554068)
30. J.D. Sackner-Bernstein, H.A. Skopicki, and K.D. Aaronson Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure Circulation 111 2005 1487 1491 (Pubitemid 40470642)
31. B.J. Wilkins, L.J. De Windt, and O.F. Bueno Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth Mol Cell Biol 22 2002 7603 7613
32. K. Schwartz, K.R. Boheler, D. de la Bastie, A.M. Lompre, and J.J. Mercadier Switches in cardiac muscle gene expression as a result of pressure and volume overload Am J Physiol 262 1992 R364 R369
33. T. Kikuchi, N. Oka, A. Koga, H. Miyazaki, H. Ohmura, and T. Imaizumi Behavior of caveolae and caveolin-3 during the development of myocyte hypertrophy J Cardiovasc Pharmacol 45 2005 204 210 (Pubitemid 40328141)
34. B. Aravamudan, D. Volonte, and R. Ramani Transgenic overexpression of caveolin-3 in the heart induces a cardiomyopathic phenotype Hum Mol Genet 12 2003 2777 2788 (Pubitemid 37407114)